FDA Inspection 1056225 — UCB Farchim SA
The FDA completed an inspection of UCB Farchim SA on April 30, 2018 in Bulle. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 30, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bulle (Switzerland)